home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next

AAV Manufacturing — Overcoming the Challenges of Plasmid DNA

  October 25, 2022  
Xtalks, online
2022 -11-30

AAV manufacturing and other types of advanced therapy production are experiencing challenges associated with their plasmid DNA supply. This includes slow or delayed production and poor DNA quality (owing to unstable or difficult sequences), impacting their ability to meet drug development timelines and regulatory demands.
In this webinar, the featured speakers will address the challenges of plasmid DNA in AAV manufacturing and present data and supportive case studies which introduce an alternative to plasmid DNA — an enzymatic, antibiotic-free DNA vector called doggybone DNA (dbDNA™).
Register to learn how doggybone DNA can eliminate many issues around complex or unstable sequences in AAV production, alongside improved speed to manufacture, safety and scalability.
Organized by: Xtalks
Invited Speakers: Dr. Lisa Caproni, Head of Vaccine Therapy, Touchlight Dr. Leszek Lisowski, Unit Head, Children's Medical Research Institute, University of Sydney
Deadline for Abstracts: 2022 -11-30
Registration: Free registration
E-mail: ajuurinen@xtalks.com
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2022 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.